Valuation: Hikma Pharmaceuticals PLC

Market Cap 4.35B 3.81B 3.52B 3.24B 6.12B 419B 6.21B 42.11B 16.5B 205B 16.33B 15.97B 706B P/E 2026 *
11.1x
P/E 2027 * 9.98x
Enterprise Value 5.82B 5.1B 4.71B 4.33B 8.19B 561B 8.32B 56.35B 22.08B 275B 21.85B 21.37B 945B EV / Sales 2026 *
1.68x
EV / Sales 2027 * 1.57x
Free-Float
63.65%
Yield 2026 *
4.08%
Yield 2027 * 4.34%
1 day-1.35%
1 week-2.78%
Current month+1.32%
1 month+5.70%
3 months+11.68%
6 months-0.19%
Current year-0.65%
1 week 1,483
Extreme 1483
1,573
1 month 1,469
Extreme 1469
1,762
Current year 1,187
Extreme 1187
1,762
1 year 1,187
Extreme 1187
2,052
3 years 1,187
Extreme 1187
2,360
5 years 1,174.5
Extreme 1174.5
2,703
10 years 814.2
Extreme 814.2
2,768
Manager TitleAgeSince
Chief Executive Officer 69 2025-11-30
Director of Finance/CFO - 2026-02-25
Chief Tech/Sci/R&D Officer 64 2026-02-25
Director TitleAgeSince
Director/Board Member 69 2005-10-13
Director/Board Member 54 2025-12-14
Chairman 69 2014-05-14
Date Insider Type Main position Quantity % Market Cap.
6/1/26 Sell

Investor Relations Manager

-26,558 0.0124%
6/1/26 Fiscal year

Chief Executive Officer

91,812 0.0427%
6/1/26 Fiscal year

Investor Relations Manager

11,664 0.0054%
Change 5-day change 1-year change 3-year change Capi.($)
-1.35%-2.78%-23.38%-21.09% 4.42B
-2.73%-3.51%+48.62%+152.87% 1,051B
-1.67%-3.18%+52.00%+56.75% 609B
-0.44%+2.14%+33.88%+84.04% 450B
-0.75%-1.46%+28.32%+22.33% 330B
-1.52%-0.95%+33.38%+38.39% 284B
-1.70%-3.54%+20.26%+17.88% 263B
-0.58%+1.78%-20.89%-38.37% 223B
-0.58%+0.21%+23.55%+56.94% 198B
-0.80%+2.60%+23.09%+68.71% 167B
Average -0.40%+0.34%+21.88%+43.84% 357.95B
Weighted average by Cap. +0.31%+0.02%+35.18%+75.46%

Financials

2026 *2027 *
Net sales 3.46B 3.03B 2.8B 2.58B 4.87B 334B 4.94B 33.51B 13.13B 163B 12.99B 12.71B 562B 3.61B 3.17B 2.93B 2.69B 5.09B 349B 5.17B 35.01B 13.72B 171B 13.57B 13.28B 587B
Net income 405M 355M 328M 301M 570M 39.03B 579M 3.92B 1.54B 19.1B 1.52B 1.49B 65.77B 443M 388M 359M 330M 623M 42.68B 633M 4.29B 1.68B 20.88B 1.66B 1.63B 71.92B
Net Debt 1.47B 1.29B 1.19B 1.1B 2.07B 142B 2.1B 14.24B 5.58B 69.39B 5.52B 5.4B 239B 1.31B 1.15B 1.07B 979M 1.85B 127B 1.88B 12.73B 4.99B 62.03B 4.94B 4.83B 214B
Logo Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC is a multinational pharmaceutical company engaged in the development, manufacturing and marketing of a broad range of generic, branded and non-licensed pharmaceutical products. Its pharmaceutical operations are conducted through three business segments: Injectables, Branded and Generics. It supplies hospitals across its markets with generic and specialty injectable products, supported by its manufacturing facilities in the United States (US), Europe and Middle East/North Africa (MENA). It supplies branded generic and in-licensed patented products from its local manufacturing facilities to retail and hospital customers across the MENA region. It supplies oral, respiratory and other generic and specialty products to the North American retail market. Its manufacturing facilities in the US supply generic and specialty products to the US and Canada markets across a broad range of therapeutic areas, including respiratory, oncology and pain management.
Employees
9,400
Date Price Change Volume
26-07-20 GBX 1,540.00 -1.35% 672,234
26-07-17 GBX 1,561.00 +0.64% 1,494,149
26-07-16 GBX 1,551.00 +3.75% 904,819
26-07-15 GBX 1,495.00 -0.07% 752,708
26-07-14 GBX 1,496.00 -4.96% 928,305
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
20.67USD
Average target price
24.88USD
Spread / Average Target
+20.36%

Quarterly revenue - Rate of surprise